DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy

scientific article published on 17 June 2014

DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/BJC.2014.337
P932PMC publication ID4134497
P698PubMed publication ID24937670
P5875ResearchGate publication ID263165306

P50authorMichal MikulaQ41204665
Jerzy OstrowskiQ41204676
Michalina DabrowskaQ82909499
Agnieszka PaziewskaQ89454650
P2093author name stringD Jarosz
K Goryca
J Dobruch
A Antoniewicz
A Borowka
L Zapala
P2860cites workBioconductor: open software development for computational biology and bioinformaticsQ21194861
Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarraysQ21562455
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genesQ24534395
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Common gene pathways and families altered by DNA methylation in breast and prostate cancersQ27025145
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation dataQ30578296
Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliabilityQ33721845
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancerQ33949373
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancerQ34100603
Identification of new differentially methylated genes that have potential functional consequences in prostate cancerQ34465132
Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis.Q34798098
Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancerQ34805223
PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 updateQ35631144
Applicability of biomarkers in the early diagnosis of prostate cancerQ35821838
The use of receiver operating characteristic curves in biomedical informaticsQ36274414
Regulators of gene expression as biomarkers for prostate cancerQ36439912
Molecular markers of prostate cancerQ36669988
Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylationQ36695645
Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancerQ36730582
Biomarker selection for medical diagnosis using the partial area under the ROC curveQ37582129
Discovery of prostate cancer biomarkers by microarray gene expression profilingQ37656262
Epigenetics in Prostate Cancer: Biologic and Clinical RelevanceQ37896315
DNA methylation changes in prostate cancer.Q37987501
Current challenges in development of differentially expressed and prognostic prostate cancer biomarkersQ38042634
APC gene hypermethylation and prostate cancer: a systematic review and meta-analysisQ38072660
Molecular diagnosis of prostate cancer: are we up to age?Q38117452
Complications of prostate biopsyQ38123203
Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detectionQ38128377
Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.Q39278530
A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategyQ39525018
EFEMP1 as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression ProfilingQ39542482
Prostate cancer detection with office based saturation biopsy in a repeat biopsy populationQ39687621
Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detectionQ39713070
The 20-core prostate biopsy protocol--a new gold standard?Q39825591
Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores?Q39835651
Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsyQ39898872
Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancerQ40002499
How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?Q41255229
Benign mimics of prostatic adenocarcinoma on needle biopsyQ41758887
DNA Methylation and the HOXC6 Paradox in Prostate CancerQ42585509
Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors.Q45981687
Saturation technique does not improve cancer detection as an initial prostate biopsy strategyQ48735293
A model for the number of cores per prostate biopsy based on patient age and prostate gland volumeQ52248568
Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate MassageQ57565212
Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancerQ74468532
Prostate cancer detection with two sets of ten-core compared with two sets of sextant biopsiesQ77182082
Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluationQ80404952
The role of combined measurement of tissue mRNA levels of AMACR and survivin in the diagnosis and risk stratification of patients with suspected prostate cancerQ84423157
The Long and Winding Road to FDA Approval of a Novel Prostate Cancer Test: Our StoryQ85564990
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectDNA methylationQ874745
P304page(s)781-789
P577publication date2014-06-17
P1433published inBritish Journal of CancerQ326309
P1476titleDNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy
P478volume111

Reverse relations

cites work (P2860)
Q89339863A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer
Q37687723A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors.
Q35871560A novel analysis strategy for integrating methylation and expression data reveals core pathways for thyroid cancer aetiology.
Q39210166Analysis of the interplay between methylation and expression reveals its potential role in cancer aetiology
Q48145024Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.
Q55059193Concurrent Hepsin overexpression and adenomatous polyposis coli deletion causes invasive prostate carcinoma in mice.
Q36336025Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies
Q33755160Exploiting Epigenetic Alterations in Prostate Cancer
Q33568125Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns
Q55317207Genomic DNA Methylation-Derived Algorithm Enables Accurate Detection of Malignant Prostate Tissues.
Q38923075HES5 silencing is an early and recurrent change in prostate tumourigenesis
Q37093141Identification of novel candidate drivers connecting different dysfunctional levels for lung adenocarcinoma using protein-protein interactions and a shortest path approach
Q40985522Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.
Q38998986Prospective Study of CRMP4 Promoter Methylation in Prostate Biopsies as a Predictor For Lymph Node Metastases
Q37701479RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
Q42376068RIFS: a randomly restarted incremental feature selection algorithm.
Q33779684SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains
Q91750819SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy
Q36184277SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.
Q26749545The importance of DNA methylation in prostate cancer development
Q37327806Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma
Q64940925Voltammetric Application of Polypyrrole-Modified Microelectrode Array for the Characterization of DNA Methylation in Glutathione S-Transferase Pi 1.

Search more.